To Radiate or Not to Radiate? Updates to Management of Retroperitoneal Sarcoma
Retroperitoneal sarcomas (RPS), a rare subset of soft tissue sarcomas, account for 10-15% of these cases and are distinguished by their substantial size, infiltrative nature, and proximity to vital anatomical structures.
Category
  • Sarcoma
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Radiation as an Immune Catalyst: Techniques, Biology and Biomaterials for Enhancing Tumor Control
Increasing evidence has demonstrated the importance of immunomodulation on tumor control. Radiotherapy, specifically, can produce a multitude of local and systemic immunomodulatory effects, including reprogramming the tumor microenvironment and exposing tumor antigens via in situ vaccination.
Category
  • Immunotherapy
  • Radiobiology
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
ASTRO/KCA Joint Activity: Stereotactic Radiotherapy and Renal Cell Cancer, Overcoming Radioresistance and the Resistance to Radiate
This activity brings together an international panel and multidisciplinary expertise to discuss the emerging role of SABR to the primary in renal cell carcinoma (RCC).
Category
  • SBRT
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Designing, Implementing and Interpreting Patient Reported Outcomes in Clinical Investigation
Patient reported outcomes (PROs) are a key component of evaluating cancer therapy. For clinical trialists, the proper design, implementation and evaluation of patient reported outcomes is critical for designing studies that will impact and inform daily practice.
Category
  • Professional Development
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Contemporary Multi-Disciplinary Management of Bladder Cancer
The management of bladder cancer is evolving across the spectrum of disease and stage and this educational activity is extremely valuable to the ASTRO membership.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
ASTRO/ILROG Joint Activity: The Comeback of RT – Radiation Therapy is Back in the Frontline of Managing Hodgkin and Indolent Lymphomas
Given the rarity of lymphomas, many clinicians are not using radiation therapy appropriately in the frontline setting.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
The Fast CAR Race: Where Does Radiotherapy Place? Challenging Cases in the Cellular Therapy Era
This activity includes four challenging cases in lymphoma and myeloma with a panel of expert radiation oncologists, including one in private practice, and a medical oncologist. 1. Urgent need for debulking in extramedullary relapse of multiple myeloma after BCMA-targeted CAR T-cell therapy.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
RO Principles & Practice: Limited Stage Small Cell Lung Cancer
This presentation focuses on the principles and practice for limited stage small cell lung cancer, an aggressive cancer which accounts for 25% of all lung cancer deaths.
Category
  • Thoracic
  • RO Principles & Practice
Format
  • Sessions onDemand
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Certificate of Attendance
Cost $149.00
RO Principles & Practice: Histology-Driven Management of Soft Tissue Sarcoma
This presentation is aimed at residents in advanced years of training and attending physicians seeking a practical update on the management of patients with soft tissue sarcoma.
Category
  • Sarcoma
  • RO Principles & Practice
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
RO Principles & Practice: Pediatric Medulloblastomas and Primitive Neuroectodermal Tumors
This presentation provides a review of workup, staging, and management of pediatric medulloblastomas and primitive neuroectodermal tumors (PNETs) including treatment planning considerations and future directions.
Category
  • Sarcoma
  • RO Principles & Practice
Format
  • Sessions onDemand
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Certificate of Attendance
Cost $149.00

Pages